Inventor · disambiguated record
Daniel J. Kerkman
Also filed as: KERKMAN DANIEL · KERKMAN DANIEL J · KERKMAN DANIEL JOSEPH
18 granted patents·6 pending applications·328 citations·filing 1984–2008
95Inventor score
Files withMOLECULAR GERIATRICS CORP11ABBOTT LAB8APPLIED NEUROSOLOUTIONS1APPLIED NEUROSOLUTIONS FORMALL1MOLECUALR GERIATRICS CORP1
Top patents by PatentIndex Score
24 records- 0194US5326776AAngiotensin II receptor antagonistsABBOTT LAB·Filed 1993·Granted Jul 5, 1994·92 cites·26 claims
- 0293US5250548AAngiotensin II receptor antagonistsABBOTT LAB·Filed 1992·Granted Oct 5, 1993·57 cites·16 claims
- 0390US4618683ATetrahydro-6,7-dimethoxy-1H-benz[e]isoinodolines useful in the treatment of hypertension and as sedativesABBOTT LAB·Filed 1984·Granted Oct 21, 1986·24 cites·17 claims
- 0483US6864062B2Purified antigen for Alzheimer's disease and methods of obtaining and using sameMOLECULAR GERIATRICS CORP·Filed 2001·Granted Mar 8, 2005·22 cites·5 claims
- 0581US6214994B1Certain substituted 1-aryl-3-piperazin-1′-yl propanonesMOLECULAR GERIATRICS CORP·Filed 1999·Granted Apr 10, 2001·22 cites·3 claims
- 0676US5693804ASubstituted 1-aryl-3-piperazin-1'-yl propanonesMOLECULAR GERIATRICS CORP·Filed 1994·Granted Dec 2, 1997·17 cites·11 claims
- 0775US5210206A1,3-oxazolyl substituted biphenylABBOTT LAB·Filed 1992·Granted May 11, 1993·15 cites·6 claims
- 0874US5185363AUrea based lipoxygenase inhibiting compoundsABBOTT LAB·Filed 1991·Granted Feb 9, 1993·16 cites·5 claims
- 0964US2008181883A1Purified Antigen for Alzheimer's Disease and Methods of Obtaining and Using SameAPPLIED NEUROSOLUTIONS FORMALL·Filed 2008·Application pending·0 cites
- 1063US5658909ACertain substituted 1-aryl-3-piperazin-1'-yl propanones to treat Alzheimer's DiseaseMOLECULAR GERIATRICS CORP·Filed 1994·Granted Aug 19, 1997·23 cites·5 claims
- 1162US5559144AFuryl and thienyl alkynyl-N-hydroxy urea derivativesABBOTT LAB·Filed 1995·Granted Sep 24, 1996·8 cites·8 claims
- 1261US5389638ATetrahydroisoquinolines as alpha-2 antagonists and biogenic amine uptake inhibitorsABBOTT LAB·Filed 1993·Granted Feb 14, 1995·7 cites·10 claims
- 1359US5705501ACertain substituted 1-aryl-3-morpholinopropanones to treat Alzheimer's DiseaseMOLECULAR GERIATRICS CORP·Filed 1994·Granted Jan 6, 1998·18 cites·6 claims
- 1455US5476873AAcetylene derivatives having lipoxygenase inhibitory activityABBOTT LAB·Filed 1994·Granted Dec 19, 1995·4 cites·7 claims
- 1551US7173132B2Certain substituted 1-aryl-3-piperazine-1′-yl propanonesMOLECULAR GERIATRICS CORP·Filed 2002·Granted Feb 6, 2007·0 cites·2 claims
- 1650US2009022825A1Method for Predicting Whether Subjects With Mild Cognitive Impairment (MCI) Will Develop Alzheimer's DiseaseAPPLIED NEUROSOLOUTIONS·Filed 2008·Application pending·0 cites
- 1750US2005272094A1Purified antigen for Alzheimer's disease and methods of obtaining and using sameMOLECULAR GERIATRICS CORP·Filed 2005·Application pending·0 cites
- 1848US2004166536A1Method for predicting whether subjects with mild cognitive impairment (MCI) will develop Alzheimer's DiseaseMOLECULAR GERIATRICS CORP·Filed 2003·Application pending·0 cites
- 1946US2001025105A1Certain substituted 1-aryl-3-piperazine-1'-yl propanonesMOLECULAR GERIATARICS CORP·Filed 2001·Application pending·0 cites
- 2035US6075026ACertain substituted 1-aryl-3-piperazin-1'-yl propanonesMOLECULAR GERIATRICS CORP·Filed 1997·Granted Jun 13, 2000·1 cites·1 claims
- 2132US6228878B1Methods for treating or preventing alzheimer's disease using substituted 2-aryl-3-morpholinopropanonesMOLECULAR GERIATRICS CORP·Filed 1999·Granted May 8, 2001·0 cites·2 claims
- 2231US6306857B1Methods for treating or preventing alzheimer's disease using substituted 1-aryl-3-piperazin-1′-yl propanonesMOLECULAR GERIATRICS CORP·Filed 1999·Granted Oct 23, 2001·0 cites·24 claims
- 2331US5968936AMethods for treating or preventing Alzheimer's Disease using substituted 1-aryl-3-morpholinopropanonesMOLECUALR GERIATRICS CORP·Filed 1997·Granted Oct 19, 1999·2 cites·2 claims
- 2430US2002002270A1Purified antigen for alzheimer's disease, and methods of obtaining and using sameFiled 1999·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Daniel J. Kerkman files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →